Medicinal cannabis prescribing guidance updated
The Medical Board of Australia (MBA) has published new guidance for medical practitioners to clarify how to meet their professional obligations when prescribing medicinal cannabis.
The updates were announced via a media release on the MBA website on 9 July 2025, which highlighted that poor medicinal cannabis prescribing practices and surging patient demand is leading to significant patient harm.
The guidance translates information from practitioners’ codes of conduct and other related guidelines to support best practice; highlights important considerations when prescribing medicinal cannabis; and calls out examples of poor practice in this space.
This year, the Faculty of Pain Medicine has started the process of reviewing PS10(PM) "Medicinal Cannabis" and chronic non-cancer pain. In 2022 the Faculty published a Community Information fact sheet on the topic.
